Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Major basic protein 1 (MBP1), also known as eosinophil granule major basic protein 1, is a highly cationic protein predominantly found in the crystalline core of eosinophil granules. It plays a central role in host defense against parasitic infections and contributes to immune hypersensitivity reactions. MBP1 acts as a cytotoxin and helminthotoxin, damaging epithelial cells and inducing inflammation. It is implicated in allergic diseases like asthma and is found at high levels in placenta/pregnancy serum.
Direct cytotoxicity toward target cells; induction of inflammation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Major Basic Protein 1 (eMBP1).